Keywords
Last Name
Institution

Eduardo Farias

TitleASSISTANT PROFESSOR
InstitutionMount Sinai
DepartmentHematology and Medical Oncology
Address

     Bibliographic 
     selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Wen HC, Avivar-Valderas A, Sosa MS, Girnius N, Farias EF, Davis RJ, Aguirre-Ghiso JA. p38a Signaling Induces Anoikis and Lumen Formation During Mammary Morphogenesis. Sci Signal. 2011; 4(174):ra34.
      View in: PubMed
    2. Ratnam KK, Feng X, Chuang PY, Verma V, Lu TC, Wang J, Jin Y, Farias EF, Napoli JL, Chen N, Kaufman L, Takano T, D'Agati VD, Klotman PE, He JC. Role of the retinoic acid receptor-a in HIV-associated nephropathy. Kidney Int. 2011 Mar; 79(6):624-34.
      View in: PubMed
    3. Marzan CV, Kupumbati TS, Bertran SP, Samuels T, Leibovitch B, Mira-y-Lopez R, Ossowski L, Farias EF. Adipocyte derived paracrine mediators of mammary ductal morphogenesis controlled by retinoic acid receptors. Dev Biol. 2011 Jan 15; 349(2):125-36.
      View in: PubMed
    4. Cohn E, Ossowski L, Bertran S, Marzan C, Farias EF. RARa1 control of mammary gland ductal morphogenesis and wnt1-tumorigenesis. Breast Cancer Res. 2010; 12(5):R79.
      View in: PubMed
    5. Paredes-Gamero EJ, Medeiros VP, Farias EH, Justo GZ, Trindade ES, Andrade-Lopes AL, Godinho RO, de Miranda A, Ferreira AT, Tersariol IL, Nader HB. Heparin induces rat aorta relaxation via integrin-dependent activation of muscarinic M3 receptors. Hypertension. 2010 Oct; 56(4):713-21.
      View in: PubMed
    6. Farias EF, Petrie K, Leibovitch B, Murtagh J, Chornet MB, Schenk T, Zelent A, Waxman S. Interference with Sin3 function induces epigenetic reprogramming and differentiation in breast cancer cells. Proc Natl Acad Sci U S A. 2010 Jun 29; 107(26):11811-6.
      View in: PubMed
    7. Lu Y, Bertran S, Samuels TA, Mira-y-Lopez R, Farias EF. Mechanism of inhibition of MMTV-neu and MMTV-wnt1 induced mammary oncogenesis by RARalpha agonist AM580. Oncogene. 2010 Jun 24; 29(25):3665-76.
      View in: PubMed
    8. Sequeira SJ, Wen HC, Avivar-Valderas A, Farias EF, Aguirre-Ghiso JA. Inhibition of eIF2alpha dephosphorylation inhibits ErbB2-induced deregulation of mammary acinar morphogenesis. BMC Cell Biol. 2009; 10:64.
      View in: PubMed
    9. Sequeira SJ, Ranganathan AC, Adam AP, Iglesias BV, Farias EF, Aguirre-Ghiso JA. Inhibition of proliferation by PERK regulates mammary acinar morphogenesis and tumor formation. PLoS One. 2007; 2(7):e615.
      View in: PubMed
    10. Kupumbati TS, Cattoretti G, Marzan C, Farias EF, Taneja R, Mira-y-Lopez R. Dominant negative retinoic acid receptor initiates tumor formation in mice. Mol Cancer. 2006; 5:12.
      View in: PubMed
    11. Farias E, Lu M, Li X, Schnapp LM. Integrin alpha8beta1-fibronectin interactions promote cell survival via PI3 kinase pathway. Biochem Biophys Res Commun. 2005 Apr 1; 329(1):305-11.
      View in: PubMed
    12. Farias EF, Marzan C, Mira-y-Lopez R. Cellular retinol-binding protein-I inhibits PI3K/Akt signaling through a retinoic acid receptor-dependent mechanism that regulates p85-p110 heterodimerization. Oncogene. 2005 Feb 24; 24(9):1598-606.
      View in: PubMed
    13. Farias EF, Ong DE, Ghyselinck NB, Nakajo S, Kuppumbatti YS, Mira y Lopez R. Cellular retinol-binding protein I, a regulator of breast epithelial retinoic acid receptor activity, cell differentiation, and tumorigenicity. J Natl Cancer Inst. 2005 Jan 5; 97(1):21-9.
      View in: PubMed
    14. Farias EF, Arapshian A, Bleiweiss IJ, Waxman S, Zelent A, Mira-Y-Lopez R. Retinoic acid receptor alpha2 is a growth suppressor epigenetically silenced in MCF-7 human breast cancer cells. Cell Growth Differ. 2002 Aug; 13(8):335-41.
      View in: PubMed
    15. Farias E, Ranuncolo S, Cresta C, Specterman S, Armanasco E, Varela M, Lastiri J, Pallotta MG, Bal de Kier Joffe E, Puricelli L. Plasma metalloproteinase activity is enhanced in the euglobulin fraction of breast and lung cancer patients. Int J Cancer. 2000 Jul 20; 89(4):389-94.
      View in: PubMed
    16. Aguirre-Ghiso JA, Frankel P, Farias EF, Lu Z, Jiang H, Olsen A, Feig LA, de Kier Joffe EB, Foster DA. RalA requirement for v-Src- and v-Ras-induced tumorigenicity and overproduction of urokinase-type plasminogen activator: involvement of metalloproteases. Oncogene. 1999 Aug 19; 18(33):4718-25.
      View in: PubMed
    17. Alonso DF, Tejera AM, Farias EF, Bal de Kier Joffe E, Gomez DE. Inhibition of mammary tumor cell adhesion, migration, and invasion by the selective synthetic urokinase inhibitor B428. Anticancer Res. 1998 Nov-Dec; 18(6A):4499-504.
      View in: PubMed
    18. Alonso D, Bertolesi G, Farias E, Gomez D, Joffe E. Inhibition of fibrinolysis by a synthetic urokinase inhibitor enhances lung colonization of metastatic murine mammary tumor cells. Oncol Rep. 1996 Nov; 3(6):1055-8.
      View in: PubMed
    Farias's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts
    _
    Co-Authors
    _
    Similar People
    _
    Same Department
     
    Mount Sinai Profiles is managed by Conduits - The Institutes for Translational Sciences at Icahn School of Medicine, supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences of the National Institutes of Health through Grant Number UL1TR000067